Back to search

National and Kapodistrian University of Athens

Εκτίμηση της σημασίας του υποδοχέα οιστρογόνων τύπου β ( ERβ) στον καρκίνο του μαστού

Abstract

dc:description

Estrogen Receptor alpha (ERa) is a marker of good prognosis and prediction of response of breast cancer to hormonal therapy. The second type of estrogen receptor (ERß) is expressed in normal and malignant breast cells mainly through two isoforms, ERßl and ERß2, the role of which in breast cancer prognosis and prediction of response to tamoxifen remains unclear.In the present study we describe the production and characterization of monoclonal and polyclonal antibodies that specifically recognize ERßl or ERß2, as well as monoclonal and polyclonal antibodies to ERa. These antibodies were successfully used for the detection of the aforementioned subtypes and isoforms of ER using a range of immunological techniques such as Western blot, immunoprécipitation, ELISA, immunocytochemistry and immunohistochemistry.We also describe the generation of MCF-7 clones that stably express ERßl or ERß2 which allowed for the investigation of the effect of ERßl or ERß2 on the ERa- mediated activation of the proliferation of the cells by estradiol and the its inhibition by tamoxifen, both in vitro and after grafting the cells in immunosuppressed mice. We found that the expression of ERßl, but not ERß2, increases the rate of growth of MCF-7 cells in the presence of estradiol and enhances the growth inhibitory effect of tamoxifen and raloxifene; and that MCF-7 cells that overexpress ERßl exhibit higher, but reversible by tamoxifen, rate of tumor growth in immunosuppressed mice when compared to parental cells.Eighty two (82) paraffin-embedded breast tumors from patients that had received tamoxifen as exclusive adjuvant therapy were immunohistochemically analyzed, using the antibodies that are capable to discriminate between the isoforms of ERß. High expression of ERßl was positively correlated with patient response to tamoxifen and absence of recurrence up to 50 months after surgery. Tumors with low ERßl expression were generally characterized by bigger size and higher grade. The immunohistochemical expression of ERßl was correlated only with that of ERß2. The results of this study show that ERßl can enhance their sensitivity of breast cancer to tamoxifen. Hence, the assessment of ERßl expression levels may be of importance as regards assessment of the overall prognosis and the prediction of response of breast cancer to endocrine therapy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2006

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dimolea, Eugenios
  • Δημολέα, Ευγενίος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24112

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dimolea, Eugenios; Δημολέα, Ευγενίος. Εκτίμηση της σημασίας του υποδοχέα οιστρογόνων τύπου β ( ERβ) στον καρκίνο του μαστού. National and Kapodistrian University of Athens, 2006. http://hdl.handle.net/10442/hedi/24112